09:54 AM EST - Appili Therapeutics Inc. : Announced its financial and operational results for the fiscal year ended March 31, 2023. The net loss and comprehensive loss of $9.2 million or $0.08 loss per share for the year ended March 31, 2023, was $15.9 million lower than the net loss and comprehensive loss of $25.1 million or $0.38 loss per share during the year ended March 31, 2022. Appili Therapeutics Inc.
shares T.APLI are trading unchanged at $0.04.
